Advertisement
Advertisement
MAIA
MAIA Biotechnology, Inc.
1.99
USDSponsored
+0.08
+4.03%
Feb 06, 15:59 UTC -5
Closed
After-Market
1.98
-0.01
-0.35%
MAIA Earnings Reports
Positive Surprise Ratio
MAIA beat 8 of 12 last estimates.
67%
Next Report
Date of Next Report
Mar 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.13
Implied change from Q3 25 (Revenue/ EPS)
--
/-51.85%
Implied change from Q4 24 (Revenue/ EPS)
--
/+8.33%
MAIA Biotechnology, Inc. earnings per share and revenue
On Nov 07, 2025, MAIA reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -39.32% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -51.85% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were MAIA Biotechnology, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MAIA Biotechnology, Inc. reported EPS of -$0.27, missing estimates by -39.32%, and revenue of $0.00, 0% as expectations.
How did the market react to MAIA Biotechnology, Inc.'s Q3 2025 earnings?
The stock price moved up 2.68%, changed from $1.12 before the earnings release to $1.15 the day after.
When is MAIA Biotechnology, Inc. expected to report next?
The next earning report is scheduled for Mar 19, 2026.
What are the forecasts for MAIA Biotechnology, Inc.'s next earnings report?
Based on 3
analysts, MAIA Biotechnology, Inc. is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement